Adam R. Kalbermatten - 01 Jul 2026 Form 4/A - Amendment Insider Report for KORU Medical Systems, Inc. (KRMD)

Reporting relationship: President and CEO
Issuer ticker: KRMD
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 13 Jul 2026, 16:06:19 UTC
Original report date: 02 Jul 2026
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Adams - Attorney-in-Fact

Key filing fact

Adam R. Kalbermatten filed Form 4/A - Amendment for KORU Medical Systems, Inc. (KRMD) on 13 Jul 2026.

Key facts

This page summarizes Adam R. Kalbermatten's Form 4/A - Amendment filing for KORU Medical Systems, Inc. (KRMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Jul 2026, 16:06.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002080271 Primary reporting owner

KALBERMATTEN ADAM R

Relationship: President and CEO
Address: C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH
Signature: /s/ Thomas Adams - Attorney-in-Fact
Signature date: 13 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD transaction Derivative

Performance Stock Unit

Award

Transaction value
Shares: +284,091
Change %
Price: $0.000000^*
Shares after: 284,091
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 284,091
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Performance stock unit awards pursuant to reporting person's amended and restated employment agreement, of which 213,068 may vest based on a target of the Company's net sales growth on or prior to 12/31/2030 and 71,023 may vest based on a target of the Company's market capitalization at 12/31/2030.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.